Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

KTTA Stock Forecast, Price Targets, Chart, Dividends & Analysis

Pasithea Therapeutics Corp

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

2.82
 
USD
  
-0.09
  
(-3.09%)
Previous close: 2.91  Open: 3.11  Bid: 2.81  Ask: 3.0
52 week range    
2.80   
   17.40
Mkt Cap: 4 M  Avg Vol (90 Days): 949,222
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 6th December 2024

Stock Rankings

80
Value
36
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

KTTA Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23
Amortization of intangibles9 M8 M
Basic EPS from continuing operations-4.2-12.64
Basic EPS total-4.2-11.0-13.01
Basic weighted shares outstanding520233.01 M1 M
BasicDiscontinuousOperations-0.37
Cost of sales17275.0-113195.0
Depreciation-1379.05094.018290.0
DepreciationAndAmortization-1379.05094.018290.0
Diluted EPS total-10.6-13.01
Diluted normalized net income/share-12.64
Diluted weighted shares outstanding517505.01 M1 M
DilutedDiscontinuousOperations-0.37
GainOnSaleOfPPE65048.0
GainsLossOnDisposalOfDiscontinuedOperations373364.0-518958.0
GeneralAndAdministrativeExpense10 M8 M
Gross operating profit-2213.0373364.0
ImpairmentOfCapitalAssets-1 M
Income before tax-2 M-12 M-16 M
Income restructuring and M&A-1000000.0
InterestExpenseNonOperating508.0102.0
MiscOtherSpecialCharges2 M2 M471613.0
Net income from total operations-2 M-14 M-16 M
NetIncomeCommonStockholders-2 M-14 M-16 M
NetIncomeContinuousOperations-2 M-14 M-16 M
NetIncomeDiscontinuousOperations-2 M-453910.0
NetNonOperatingInterestIncomeExpense-508.0-102.0-415368.0
NonRecurringOperationExpense1 M
Normalized income-17 M
Operating income-5 M-13 M-16 M
Operating income before depreciation (EBITDA)-2 M-12 M-15 M
OperatingExpense5 M13 M16 M
Other income net-2 M-2 M56245.0
OtherGainLossFromDispositionOfDiscontinuedOperations-2 M-453910.0
OtherGandA10 M8 M
OtherOperatingExpenses698000.0243230.0
ProvisionForGainLossOnDisposal-65048.0
Research & development expense3 M8 M
ResearchExpense3 M8 M
RestructringAndMnAIncome-1000000.0
Revenue per share9 M8 M
SalariesAndWages-641181.0-440000.0
Selling Gen & administrative expense5 M10 M8 M
SellingAndMarketingExpense5 M13 M
SellingExpense5 M13 M
Special income/charges-1 M1000000.0
Total Income available for interest expense (EBIT)-2 M-12 M-16 M
Total common shares outstanding3 M1 M
Total net income-2 M-14 M-16 M
Total ordinary shares1 M1 M1 M
Total revenues15062.0486559.0
TotalExpenses5 M13 M16 M
TotalRevenue15062.0486559.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University